Yongin-si, South Korea

Wooyoung Choi



Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Wooyoung Choi: Innovator in Pneumococcal Conjugate Compositions

Introduction

Wooyoung Choi, an accomplished inventor based in Yongin-si, South Korea, has made significant contributions to vaccine development. With a total of two patents to his name, Choi's work focuses on improving prophylactic strategies against pneumococcal infections.

Latest Patents

Choi’s latest patents include innovative multivalent pneumococcal polysaccharide-protein conjugate compositions. The first patent provides compositions that feature 20 different pneumococcal capsular polysaccharide-protein conjugates, each comprising a capsular polysaccharide from diverse serotypes. These serotypes include variants such as 1, 3, 4, 5, and others, conjugated to tetanus toxoid or CRM. Additionally, this invention outlines methods for producing these compositions and their potential applications for disease prevention.

Similarly, the second patent focuses on compositions with 16 different pneumococcal capsular polysaccharide-protein conjugates. This formulation is designed to enhance immune response through targeted serotype combinations, facilitating better prophylactic measures against pneumococcal diseases.

Career Highlights

Throughout his career, Wooyoung Choi has garnered experience with notable companies in the biopharmaceutical sector. He has worked at Sanofi Pasteur Inc. and SK Bioscience Co., Ltd., where his research and innovations have played a vital role in the advancement of vaccine technology.

Collaborations

In his journey as an inventor, Choi has collaborated with esteemed professionals, including Kyungjun An and Dongsoo Ham. These collaborations have fostered a team environment that emphasizes innovation and research excellence, contributing to the development of effective medical solutions.

Conclusion

Wooyoung Choi's commitment to enhancing public health through innovative vaccine research is evident in his patent portfolio and collaborative efforts. His work in multivalent pneumococcal polysaccharide-protein conjugate compositions holds promise for advancing prophylactic measures against serious infections. As the landscape of vaccine development continues to evolve, Choi's contributions undoubtedly position him as a significant figure in the field of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…